G1 |
Retrospective study of patients with methylmalonic acidemia by ESI-MS/MS analysis |
|
Hironori KOBAYASHI, Yuki HASEGAWA, Masahiko KIMURA, Yuka
YOTSUMOTO, |
|
Seiji YAMAGUCHI |
|
Department of Pediatrics, Shimane University School of Medicine |
|
|
G2 |
Gas chromatography-mass spectrometric measurement of 3-hydroxyglutaric acid and |
|
related metabolites in patients with glutaric aciduria type I found in newborn screening |
|
using tandem mass spectrometry. |
|
Yosuke SHIGEMATSU1, Ikue
HATA2, Go TAJIMA3, Nobuo SAKURA3, Toru
YORIFUJI4 |
|
1. Department of Health Science, School of Nursing, University of Fukui |
|
2. Department of Pediatrics, University of Fukui |
|
3. Department of Pediatrics, Hiroshima University |
|
4.
Department of Pediatrics,
kyoto University |
|
|
G3 |
Gas chromatographic-mass spectrometric diagnosis of tyrosinemia type I using filter paper |
|
absorbed urine |
|
Toshihiro SHINKA, Tomiko KUHARA |
|
Division of Human Genetics, Medical Research Institute, Kanazawa Medical University |
|
|
G4 |
Chemical Diagnosis for Primary Hyperoxaluria Type II |
|
Analysis of Optical Isomer of Glyceric Acid by GC/MS as Diastereoisomeric |
|
Derivatives| |
|
Yoshito INOUE, Toshihiro SHINKA, Morimasa OHSE, Tomiko KUHARA |
|
Division of Human Genetics, Medical Research Institute, Kanazawa Medical University |
G5 |
Studies on brain uptake of neurotoxic metabolites derived from butyrophenones by brain
microdialysis.
|
|
Yuki
MURABAYASHI1, Youji
KITAMURA1, Fumiyo
KASUYA1,
2, Kazuo
IGARASHI1,
2 |
|
1. Faculty of Pharmaceuteical Sciences, Kobegakuin University |
|
2. High technology Research Center, Kobegakuin University |
|
|
G6 |
Simple analysis of triazolam in human body fluids by
HPLC-MS/MS |
|
Xiao-Pen LEE1, Takeshi
KUMAZAWA1, Tetsuya
ARINOBU2, Hideki
HATTORI3, Hiroshi
SENO3, Keizo
SATO1
|
|
1. Department of Legal Medicine, Showa University School of Medicine |
|
2. Department of Chemistry, Aichi Medical University School of Medicine |
|
3. Department of Legal Medicine, Aichi Medical University School of Medicine |
|
|
G7 |
Examination of the simultaneous endocannabinoids assay in medical samples by LCMS/MS system |
|
Toru
OBATA1, Mayumi
NOMURA1, Youichi
KASE2, Yasumasa
TANIFUJI2 |
|
1. Department of Molecular Cell Biology, Institute of DNA Medicine, Jikei University School of Medicine |
|
2. Department of Anesthesiology, Jikei University School of Medicine |
|
|
G8 |
High-throughput quantitative analysis by laser desorption: Measurement of serum salicylate levels by
DIOS-MS |
|
Yoshinao WADA1,2, Shoji OKUNO2 |
|
1. Department of Molecular Medicine, Osaka MCHRI |
|
2. Japan Science & Technology Agency, Innovation Plaza Osaka |
W1-1 |
New MS Technologies for Medical/Clinical Applications Waters Offers
|
|
Michiko KANAI, Kiyoshi MARUNO and Katsutoshi NAGASE |
|
Nihon Waters K.K. |
|
|
W1-2 |
The Analysis Time Reduction using Fast-GC/MS and Database (organic and fatty acids) |
|
Katsuhiro NAKAGAWA, Shuichi KAWANA
|
|
SHIMADZU CORPORATION |
|
|
W1-3 |
Clinical Proteomics using SELDI-TOF MS |
|
Kenji SAITO |
|
Ciphergen Biosystems K.K. |
|
|
W1-4 |
The advantage of high resolution and high mass accuracy measurement in proteomics study produced by |
|
the Finnigan LTQ FT linear ion
trap/ICR hybrid mass spectrometer |
|
Masayuki KUBOTA |
|
Technical Lab, Thermo Electron Corporation, Yokohama, JAPAN |
|
Rapid analysis of volatile hydrocarbons in whole blood using solid-phase |
|
microextraction with gas chromatography-mass spectrometry, and its application in |
|
forensic cases to evaluate whether or not victims inhaled combustion gases and |
|
determine the gases inhaled |
|
Masanori HASEGAWA11, Yoko
HIEDA2, Haruo
TAKESHITA2, Kojiro
KIMURA3 |
|
1. Criminal Investigation Laboratory, Shimane Prefectural Police Headquarters |
|
2. Department of Legal Medicine, Shimane University School of Medicine |
|
3. Department of Legal Medicine, Graduate School of Biomedical Sciences,
Hiroshima University |
G9 |
Determination of methamphetamine and amphetamine by stir bar sorptive extraction |
|
(SBSE)-gas chromatography/mass spectrometry |
|
Takeshi
KUMAZAWA1, Kenji
HARA2, Xiao-Pen
LEE1, Tetsuya
ARINOBU3, Hideki |
|
HATTORI4, Hiroshi, SENO4, Akira
ISHII5, Osamu SUZUKI6, Keizo SATO1 |
|
1. Department of Legal Medicine, Showa University School of Medicine |
|
2. Department of Forensic Medicine, Fukuoka University School of Medicine |
|
3. Department of Chemistry, Aichi Medical University School of Medicine |
|
4. Department of Legal Medicine, Aichi Medical University School of Medicine |
|
5. Department of Legal Medicine, Fujita Health University School of Medicine |
|
6. Department of Legal Medicine, Hamamatsu University School of Medicine |
|
|
G10 |
Skin analysis of hydrocarbons for the diagnosis of dermal exposure to petroleum |
|
products in forensic and clinical cases
|
|
Yoko
HIEDA1, Yoshio
TSUJINO2, Haruo
TAKESHITA1 |
|
1. Department of Legal Medicine, Shimane University School of Medicine |
|
2. Department of Dermatology, Shimane University School of Medicine |
|
|
G11 |
Development of GC-MS Identification System for Benzodiazepines and Their Metabolites |
|
H. NISHIOKA, M. NISHIKAWA, and H. TSUCHIHASHI |
|
Forensic Science Laboratory, Osaka Prefectural Police Headquarters |
|
|
G12 |
Development and clinical meaning of analysis of SUPERUMIN in urine |
|
by GC/MS |
|
Hitoshi TANAKA1, Kenji HARA2, Masayuki
KASHIWAGI2, Mituyoshi |
|
KAGEURA2, Seiichi
KASHIMURA2, Keiichi
TANAKA1
|
|
1.Departments of Emergency and Critical Care
Medicine, Forensic Fukuoka University School of Medicine |
|
2, Departments of Emergency and Forensic
Medicine, Fukuoka University School of Medicine |
|
|
G13 |
Simultaneous determination of alpha-methyltryptamine and |
|
5-methoxy-N,N-diisopropyltryptamine in human blood and urine by GC/MS |
|
Tomomi ISHIDA, Keiko KUDO, Noriaki IKEDA |
|
Department of Forensic Pathology and Sciences, Graduate School of Medical |
|
Sciences, Kyushu University |
|
|
G14 |
MALDI-TOFMS analysis of apoptosis related-proteins in mouse hepatocyte stimulated by glycyrrhizin |
|
Shigeo IKEGAWA |
|
Department of Bioanalytical Pharmaceutics, Faculty of Pharmaceutical Sciences,
Kinki University |
|
|
G15 |
Proteomics to identify antibodies against lung
adenocarcinoma-derived |
|
proteins |
|
Toyofumi NAKANISHI1, Hitoshi MURAO2, Toru TAKEUCHI1, Isao GOTO3, Hiroyuki
SUZUKI4, Ikuya
YANO4, |
|
Akira SHIMIZU1,2 |
|
1Department of Clinical
Pathology |
|
2Central
Laboratory |
|
RFirst Internal@Medicine, Osaka Medical College, |
|
4Japan BCG Laboratory@ |
|
|
G16 |
Technical developments for improving peptide mass fingerprinting: Use of a thin-layer gel and its preparation |
|
Yoshinao
WADA1,2, Michiko
TAJIRI2 |
|
1. Department of Molecular Medicine, Osaka MCHRI |
|
2. Japan Science & Technology Agency, Innovation Plaza Osaka |
|
|
G17 |
A stable-isotopic study of placental transfer of maternal cholesterol
–part I– |
|
Shuumi
YOSHIDA1, Yoshinao
WADA1,2 |
|
1. Osaka University, Graduate School of Medicine |
|
2. Department of Molecular Medicine, Osaka MCHRI |
|
|
G18 |
LC/ESI-MS analysis of phospholipid oxidation products in rat |
|
Junko ADACHI, Naoki YOSHIOKA, Yoshimi SAEKI, Mariko SATO, Rika
FUNAE, |
|
Yasuhiro UENO |
|
Dept of Legal Medicine, Kobe University Graduate School of Medicine |
|
|
G19 |
Effect of mutated TAP2 (TAP2*Bky2) on MHC Class I presenting
peptides |
|
Gouichi KAGEYAMA1, Seiji KAWANO1, Sugayo
KANAGAWA1, Toyofumi NAKANISHI2, Akira SHIMIZU2, |
|
Masahiro KOSHIBA1, Shunichi
KUMAGAI1 |
|
1. Clinical Pathology and Immunology, Department of Biomedical Informatics, |
|
Kobe University Graduate School of Medicine@ |
|
2. Department of Clinical Pathology, Osaka Medical College@ |
|
|
|
|